Approval · Notice of Compliance 13360 · 2012
TARGIN: Notice of Compliance 13360
Issued June 6, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13360
- Date
- June 6, 2012
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New Strength; New manufacturing facility
- Therapeutic class
- Opioid Analgesic; Opioid Antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TARGIN | 02387425 | Marketed |
| TARGIN | Not yet assigned | — |
Medicinal ingredients
- NALOXONE HYDROCHLORIDE 20 MG per TAB
- OXYCODONE HYDROCHLORIDE 10 MG per TAB
- NALOXONE HYDROCHLORIDE 40 MG per TAB
- OXYCODONE HYDROCHLORIDE 20 MG per TAB
- NALOXONE HYDROCHLORIDE 2.5 MG per TAB
- OXYCODONE HYDROCHLORIDE 5 MG per TAB
- NALOXONE HYDROCHLORIDE 10 MG per TAB